about
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyCryoballoon ablation of atrial fibrillation: a practical and effective approachCardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.Reduced incidence of clinical restenosis with newer generation stents, stent oversizing, and high-pressure deployment: single-operator experienceElectrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia.Diagnostic superiority of continuous-loop electrocardiographic recording over other testing in a patient with recurrent syncope and underlying coronary artery disease with severe left ventricular dysfunction.The clinical challenge of preventing sudden cardiac death immediately after acute ST-elevation myocardial infarction.Fully transvenous cardioverter defibrillators: rare need for subcutaneous patch with two newer-generation systems.The clinical spectrum and diagnosis of syncope.Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes.Integration of intracardiac echocardiographic imaging of the left atrium with electroanatomic mapping data for pulmonary vein isolation: first-in-Greece experience with the CartoSound™ system and brief literature review.Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Clinical and pharmacological significance of alpha2-adrenoceptor polymorphisms in cardiovascular diseases.The contribution of echocardiography to cardiac resynchronisation therapy.Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.The contribution of Doppler echocardiography to the assessment of left ventricular long axis function.The deleterious consequences of right ventricular apical pacing: time to seek alternate site pacing.Rethinking target discovery in polygenic diseases.Simplified swift and safe vascular closure device deployment without a local arteriogram: Single center experience in 2074 consecutive patients.Alternate site pacing in patients at risk for heart failure.Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?Treating dyslipidemias: is inflammation the missing link?Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.Ranolazine and its Antiarrhythmic Actions.European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI."Real life" longevity of implantable cardioverter-defibrillator devices.Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial.Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.Stroke Risk Stratification Schemes in Atrial Fibrillation in the Era of Non-Vitamin K Anticoagulants: Misleading and Obsolete, at least for the Low-Risk Patients?In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.Supraventricular tachycardia. Mechanisms and therapy.Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature.Correlation of mechanical dyssynchrony with QRS duration measured by signal-averaged electrocardiography.Cardiac implantable electronic device lead extraction using the lead-locking device system: keeping it simple, safe, and inexpensive with mechanical tools and local anesthesia.Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.Transcatheter closure of patent foramen ovale during a radiofrequency ablation procedure.
P50
Q26796261-3AC8E6B0-B01A-412D-B94B-C279DAE41894Q28067645-42F28D07-21E6-45E6-978D-8F70E9936CD5Q28087763-38BD6F3F-DD42-44B3-8C3A-8D9E8E57852BQ28176308-0861E21F-5E7F-422F-9256-135C8666B634Q33145265-BCA0ADD7-078B-4551-BDDF-494BE0251D06Q33146392-7CD12B6C-DBF8-4234-B302-A7A0238B5D00Q33164931-FE60559D-8985-4C9B-95DE-D093DACED18BQ33173955-B4DCE918-0E9D-42DF-9E60-3D8A857A774FQ33174377-C4658DA6-7765-4AF6-A2E1-F9416CA9B09AQ33175613-3AEEE9AA-E34E-4868-9129-D05FF421E347Q34139843-19C29CC9-EE26-4B28-8902-DE3A4CDCD342Q34175991-E46C1621-E683-44D9-AF92-C1274725FA53Q34538645-274D8317-1808-4897-A3E9-9AE83153AACCQ35961453-A21D9E21-2880-4852-B5C1-9D9CF344C29FQ36256040-94956A1C-4587-4076-9020-87CDB149CA9EQ36296774-2FE679EB-44B0-44EF-98DC-D23C4DD45B90Q36372130-145B25AF-788B-430A-80DD-E43707964F52Q36444993-F037822A-B78C-4722-B802-691B0CB639BFQ36612143-EADABA86-AFA3-4CD9-BA5F-015363D2F2E3Q37188516-92895E07-E054-437F-A62D-B425DC52A337Q37218573-83070CC0-E753-4F3F-A80B-65A619B2C73FQ37787320-9ADBDBC8-8DA7-4D21-8663-285E6A4A4C67Q38237773-00530FEF-13F1-4879-951B-CB6D272963B4Q38406030-6DAEF5F2-C58D-4223-8378-70B9D945D7F5Q38561354-CB79357B-2F7C-45F4-A117-86BB31EBF539Q38571627-E2D5437E-0F6F-46F8-B5A1-26CFD5B9CB7EQ38635408-B6B360BF-08AE-4CA7-A099-D2B4CF41119FQ38764602-46371EB0-AFD5-4D57-AA1C-3E2317FF2370Q38784883-39CE9921-CEFE-40EB-80C9-DE72D6D70E73Q38868592-B6E95DDA-618B-4277-B5EA-67C4D9D42DE7Q39084453-7A96D00B-5DDE-4EAB-949B-D4925DF7616DQ39177912-BA24A49C-82F5-482B-B1A1-F66B16A8F891Q39423925-FC47F220-1258-4C62-AA5D-B6B06E8E4B4AQ39574323-4ACFCBD6-1DE3-4C38-9F07-3AB0EBD87E31Q39672532-426684E5-04A6-4AA5-9309-1A6306C62D60Q39672538-C723A5CA-3F07-4713-8C7E-63D17E4E943EQ39893484-40811AD3-045E-426E-BEA4-650109442F4CQ40092091-0B230E83-BD60-4869-8470-9EDE1A1BB415Q40258511-5A9416AD-EB32-4CCB-9BBD-03D4240DBA33Q40294182-0EA5BBCC-0EBD-435B-9F39-A6345AAC5BB0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Antonis S Manolis
@nl
Antonis S Manolis
@sl
Antonis S. Manolis
@en
Antonis S. Manolis
@es
type
label
Antonis S Manolis
@nl
Antonis S Manolis
@sl
Antonis S. Manolis
@en
Antonis S. Manolis
@es
prefLabel
Antonis S Manolis
@nl
Antonis S Manolis
@sl
Antonis S. Manolis
@en
Antonis S. Manolis
@es
P214
P244
P1053
F-5003-2014
P106
P1153
18335896700
P21
P213
0000 0000 8316 4318
P214
P244
P31
P3829
P3835
antonis--manolis
P4012
P496
0000-0002-0336-4745
P734
P735
P7859
lccn-n94801352